BOSTON and ATLANTA, May 10, 2022 /PRNewswire/ — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing…
Expanded partnership to make 9-1-1 Communications Officer and Certified Protection Officercertifications available to secondary school students nationwide